BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 27738331)

  • 1. miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway.
    Zhang Z; Yin J; Yang J; Shen W; Zhang C; Mou W; Luo J; Yan H; Sun P; Luo Y; Tian Y; Xiang R
    Oncotarget; 2016 Nov; 7(46):75038-75051. PubMed ID: 27738331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
    Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
    Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
    Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY
    J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-485-5p inhibits the progression of hepatocellular carcinoma through blocking the WBP2/Wnt signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Signal; 2020 Feb; 66():109466. PubMed ID: 31706018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients.
    Ashmawy AM; Elgeshy KM; Abdel Salam ET; Ghareeb M; Kobaisi MH; Amin HAA; Sharawy SK; Abdel Wahab AHA
    Arab J Gastroenterol; 2017 Sep; 18(3):144-150. PubMed ID: 28958640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J; Liu L; Zou H; Yu W
    Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
    Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
    Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propofol-induced miR-219-5p inhibits growth and invasion of hepatocellular carcinoma through suppression of GPC3-mediated Wnt/β-catenin signalling activation.
    Gong T; Ning X; Deng Z; Liu M; Zhou B; Chen X; Huang S; Xu Y; Chen Z; Luo R
    J Cell Biochem; 2019 Oct; 120(10):16934-16945. PubMed ID: 31104336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
    Sun X; Liu Y; Li M; Wang M; Wang Y
    Biomed Pharmacother; 2015 May; 72():58-65. PubMed ID: 26054676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway.
    Zhao J; Wang Y; Han M; Lu H; Chen X; Liu S; Yuan X; Han K; Liang P; Cheng J
    Cancer Sci; 2020 Mar; 111(3):994-1007. PubMed ID: 31746531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.
    Jia P; Wei G; Zhou C; Gao Q; Wu Y; Sun X; Li X
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618765221. PubMed ID: 29618288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway.
    Zheng Z; Liu J; Yang Z; Wu L; Xie H; Jiang C; Lin B; Chen T; Xing C; Liu Z; Song P; Yin S; Zheng S; Zhou L
    Oncotarget; 2016 May; 7(19):28000-12. PubMed ID: 27058905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination.
    Wen J; Xiong K; Aili A; Wang H; Zhu Y; Yu Z; Yao X; Jiang P; Xue L; Wang J
    Theranostics; 2020; 10(12):5322-5340. PubMed ID: 32373215
    [No Abstract]   [Full Text] [Related]  

  • 18. MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathway.
    Lu C; Jia S; Zhao S; Shao X
    Cancer Biomark; 2019; 25(1):115-126. PubMed ID: 31006667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-629-5p promotes growth and metastasis of hepatocellular carcinoma by activating β-catenin.
    Tao X; Yang X; Wu K; Yang L; Huang Y; Jin Q; Chen S
    Exp Cell Res; 2019 Jul; 380(2):124-130. PubMed ID: 30954576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.